Neogen Corporation Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Neogen Corporation (NEOG) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$1.90 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-07-30
- Neogen Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2026 was -$1.90M.
- Neogen Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$237.90M.
- Neogen Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$3.00M.
- Neogen Corporation effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$4.63M, a 136.61% decline from fiscal 2022.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2026-05-31 | -$1.90M 10-K · filed 2026-07-30 | |
| 2025-05-31 | -$237.90M 10-K · filed 2026-07-30 | -$237.90M 10-K · filed 2025-07-30 |
| 2024-05-31 | -$3.00M 10-K · filed 2026-07-30 | -$3.00M 10-K · filed 2024-07-30 |
| 2023-05-31 | -$4.63M 10-K · filed 2025-07-30 | |
| 2022-05-31 | $12.64M 10-K · filed 2024-07-30 | |
| 2021-05-31 | $15.81M 10-K · filed 2023-08-15 | |
| 2020-05-31 | $15.18M 10-K · filed 2022-07-27 | |
| 2019-05-31 | $15.32M 10-K · filed 2021-07-30 | |
| 2018-05-31 | $21.46M 10-K · filed 2020-07-30 | |
| 2017-05-31 | $23.34M 10-K · filed 2019-07-30 | |
| 2016-05-31 | $19.43M 10-K · filed 2018-07-27 | |
| 2015-05-31 | $18.23M 10-K · filed 2017-07-28 | |
| 2014-05-31 | $15.06M 10-K · filed 2016-07-29 | |
| 2013-05-31 | $14.40M 10-K · filed 2015-07-30 | |
| 2012-05-31 | $11.90M 10-K · filed 2014-07-30 | |
| 2011-05-31 | $12.30M 10-K · filed 2013-07-30 | |
| 2010-05-31 | $9.60M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |